Are you a new member? Sign up now
Login area
| Sign up
close
TYRUKO - 300mg/15ml - 1x15ml
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AA23 | BioTech | Natalizumab - 300mg/15ml | 12608 | 68526/1 | TYRUKO | 300mg/15ml | 1x15ml | Injectable concentrate for solution | Infusion | Droguerie Columbus | Sandoz GmbH | Austria | 90,231,010 L.L | 2.44 | E2 | Sandoz GmbH | Austria | 6/3/2026 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AA23 | BioTech | Natalizumab - 300mg/15ml | 10731 | 98820/1 | TYSABRI | 300mg/15ml | 1 x 15ml | Injectable concentrated solution | Infusion | Mersaco | Biogen Netherlands BV | The Netherlands | 126,830,594 L.L | 2.44 | E2 | Biogen Netherlands BV | The Netherlands | 6/3/2026 | |
| L04AA23 | BioTech | Natalizumab - 300mg/15ml | 10731/388 | 98820/1 | TYSABRI | 300mg/15ml | 1 x 15ml | Injectable concentrated solution | Infusion | Mersaco | Biogen Netherlands BV | The Netherlands | L.L | 2.44 | E2 | Biogen Netherlands BV | The Netherlands | 6/3/2026 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2026